×

Pharmaceutical product

Hai-O Enterprise Berhad

http://mall.hai-o.com.my

Hai-O Enterprise Berhad is a Malaysia-based company. The principal business of the Company involves wholesaling, retailing, multi-level marketing, pharmaceutical factory and modern Chinese medicinal clinics. The business segments of the Company include wholesale, multi level marketing, retail, manufacturing and others. The wholesale segment includes wholesaling and trading in herbal medicines and healthcare products, herbs and tea. The multi level marketing segment includes operating multi level direct marketing of healthcare and beauty products. The retail segment includes retail chain stores. The manufacturing segment includes manufacturing, producing and distributing pharmaceutical products, alcoholic and non-alcoholic drinks. The others segment includes businesses involving leasing of machinery and equipment, licensed money lender, insurance agent, advertising services, rental income, trading of clocks and investment holding. (Source: ARS)

  • 12/8/2013
  • 7
  • 0

D.C. Labs Limited

http://www.dclabs.on.ca

D.C. Labs Limited is a wholly owned Canadian manufacturer of pharmaceutical products operating under license by the Health Protection Branch, Government of Canada. The company was originally founded in 1932. D.C. Labs Limited is an independent organization, dedicated to developing and serving our own growing list of national and international clients. D.C. Labs Limited's extensive portfolio includes wholesale distributors, retail pharmacies, health food stores and mass merchandisers all across North America. Our modern 32,000 square-foot facility is situated on a two-acre site in the heart of Metropolitan Toronto. The plant is outfitted with the finest state-of-the-art equipment to ensure safe and efficient manufacturing, packaging, warehousing, quality assurance, sales and marketing, of our complete line of pharmaceutical and nutraceutical products. Over the past two years we have renovated our office areas and expanded production facilities to include two new departments: Encapsulation and Tableting. D.C. Labs Limited's operation now covers the entire spectrum of manufacturing: liquid, creams, capsules, tablets, caplets, and blister packaging.

  • 12/8/2013
  • 6
  • 0

Technofarma S.A.

http://www.technofarma.com

Technofarma SA is a Costa Rica-based company specializing in the distribution of pharmaceutical products, toiletries and medical equipment. The Company is structured into two main segments: Farma and Consumo. In the Farma division, it operates through a network of 829 drug stores. In the Consumo division, Technofarma SA distributes its products through 371 selling points. The Company is headquartered in San Jose, Costa Rica.

  • 12/8/2013
  • 10
  • 0

STD Pharmaceutical Products Ltd

http://www.stdpharm.co.uk

STD Pharmaceutical Products Ltd is a family run business formed in 1967 to supply a novel sclerosant to surgeons for the non surgical treatment of varicose veins. STD now offers products in two areas, sclerotherapy and tap water iontophoresis, both of which offer patients genuine alternatives to surgical procedures. The business started out making a sclerosant called Fibro-Vein. Fibro-Vein is a liquid injection which, when injected into varicose veins can close them without the need for surgery. The treatment of varicose veins with Fibro-Vein offers the patient a painless walk in, walk out procedure without anaesthesia or surgery; the veins are simply injected. For the patient, the treatment avoids the pain and time off work following surgery. Small veins such as spider and thread veins can also be injected giving excellent cosmetic results. Injection of varicose veins is also attractive to the NHS because the treatment offers savings in time and money as well as freeing up theatre time. STD also promotes tap water iontophoresis as a simple but effective (80%+) treatment for patients suffering from excessive sweating of the hands and/or feet. The non invasive procedure involves passing a low voltage electric current through the hands or feet using a water bath. The treatment protocol recommends seven 20-30 minute sessions in the first month, after which, the number of sessions can be greatly reduced and are tailored on an individual basis. Many patients only need a top up treatment every 3-4 months after the initial phase or if the sweating returns. Tap water iontophoresis using the I2M range of machines is very effective at stopping excessive sweating. The I2M range has machines suitable for clinics but also smaller units for home use; some patients buy their own machine for treatment maintenance. Although the exact mode of action is unknown the treatments provide a painless, simple non invasive first line of treatment. The alternative is an Endoscopic Thoracic Sympathectomy where the sympathetic nerve running along the spine is cut. Although sympathectamies are effective there can be some undesirable side effects. In summary, STD Pharmaceutical Products Ltd is dedicated to promoting therapy areas that provide an alternative to surgery. We currently promote the non surgical treatment of varicose veins and hyperhidrosis (excessive sweating).

  • 12/8/2013
  • 8
  • 0

Zyber Pharmaceuticals Inc

http://www.zyberrx.com

Zyber Pharmaceuticals, Inc. is a rapidly expanding pharmaceutical company which develops and markets a variety of pharmaceutical products for the entire family. Currently, Zyber is marketing a line of upper respiratory medications, which may be viewed on our products page. At Zyber, we share a commitment to family and maintaining family values and relationships at home, at the office and with our customers. Our key customer relationships are with pharmacists, doctors, nurses, nurse practitioners, physician assistants, and other health care providers. As we have expanded and grown regionally, we have afforded the opportunity for success to individuals of diverse background and culture. Visit our careers page if you would like to join in be a part of the Team Zyber. If you would like more information on our company or products, please contact us.

  • 12/8/2013
  • 6
  • 0

Topsun Science and Technology Co. , Ltd.

http://topsun.com

Topsun Science and Technology Co., Ltd. is principally engaged in the sale of prescribed pharmaceuticals and over-the-counter (OTC) pharmaceuticals. The Company is also involved in advertising agency business. During the year ended December 31, 2007, the Company obtained approximately 98% of its total revenue from the sale of pharmaceuticals. The Company operates its businesses mainly in the domestic market. As of December 31, 2007, the Company had nine major subsidiaries and associates. (Source: ARS)

  • 12/8/2013
  • 5
  • 0

Novaflux Technologies

http://www.novaflux.com

We have been developing commercially successful products for over ten years. We started with the simple and challenging task of removing biofilm from the lumen of small diameter dental tubing. As we succeeded in solving this fundamental and critical problem, removal of biofilm from narrow lumens, we realized that this was only the beginning. As a technology company, the search for novel and exciting ways to apply our patented cleaning process is without end, and we seized every opportunity. We branched out into endoscope and hemodialyzer reprocessing, moved from simple dental waterlines to dental handpiece, and then validated clean-in-place methods in the food and beverage industry. Our successful extension into membrane cleaning has made water treatment, reuse and recycling a major opportunity for the Novaflux discovery. In our journey, we learned that biofilm is not the only adhering contaminant that looses the battle against the Novaflux process. Other contenders, such as protein deposits, tissue fragments, blood and cell fragments, biofoulants, inorganic scale, humic substances, particulates such as silt and clay, milk fats and proteins, food residues, and other adhering materials, have all stepped into the ring and lost the fight with the Novaflux process. Our most recent breakthrough has been with spiral wound membranes, specifically the ability to clean them more effectively and efficiently than the current industry standard. Novaflux has evolved from a small R&D company concerned with biofilm removal, to a company that has several validated product lines that spans many industries. To read more about our products and our funded research activities, please click on the respective link.

  • 12/8/2013
  • 13
  • 0

Pronova BioPharma ASA

  • 12/8/2013
  • 7
  • 0

Valeant Canada Limited

http://www.valeantcanada.com

Valeant Canada is a specialty pharmaceutical company and is a subsidiary of Valeant Pharmaceuticals International. Valeant Canada manufactures and markets pharmaceuticals products, primarily in the areas of Neurology, Psychiatry, Pain Management and Dermatology. In 2006, Valeant Canada total revenues were $41.8 million (USD) that were generated by 39 products and more than 100 SKUs. Based in Montreal, Quebec, Valeant Canada employs 150 people.

  • 12/8/2013
  • 9
  • 0

Grand Valley Fortifiers Limited

http://www.grandvalley.com

Grand Valley Fortifiers is committed to continuous improvement through product innovation, research and development. Grand Valley Fortifiers will continue to develop new and more advanced products, making significant contributions to the production of meat, milk and eggs for improved human health.

  • 12/8/2013
  • 6
  • 0

Cary Pharmaceuticals Inc

http://www.carypharma.com

Cary Pharmaceuticals is a pharmaceutical development company. The Company is advancing the development of its three products, QuitPak®, CPI-300, and Tempol while leveraging $3.2 million in financing from its strategic development partners, Catalent Pharma Solutions and Intelgenx, and $10.8 million in NIH grants. The Company is led by an experienced management team and Board of Directors, including Douglas Cary (President), a former Abbott Laboratories executive; Carl Schwan (CFO), a former CFO for two successful initial public offerings that raised $80 million; Dr. Lester Crawford (Director), Former Commissioner of the U.S. Food and Drug Administration (FDA); and Stephen Norris (Director), Co-founder and Past President of the Carlyle Group and Chairman of SN Partners, a private equity investment firm.

  • 12/8/2013
  • 8
  • 0

BML Pharmaceuticals , Inc.

http://www.bmlpharm.com

Based in Manhasset, N.Y., BML Pharmaceuticals, Inc. researches and develops proprietary prescriptive pharmaceutical products in the areas of cancer treatment, and infectious and inflammatory diseases. BML's products are formulated into therapeutics that range from the prevention and treatment of dermal disease to the severely debilitating mucositis that is a major dose-limiting factor in radiation and chemotherapy treatment for cancer patients.

  • 12/8/2013
  • 7
  • 0

Cedar Pharmaceuticals LLC

http://www.cedarpharma.com

Cedar Pharmaceuticals LLC is a virtual pharmaceutical company, partnering with other professionals to bring quality products to the U.S. market. Our primary target products are niche generic prescription drugs. Cedar's President is David Lohrey. He has twenty years experience in the pharmaceutical business; previously working for Boots Pharmaceuticals, Knoll Pharmaceuticals, and BASF's Shreveport contract manufacturing operation. He worked in several different areas of accounting and finance. As Site Controller he was responsible for accounting, purchasing, and production planning. He is a CPA and received his BS magna cum laude and MS in Accounting from Louisiana State University, Baton Rouge.

  • 12/8/2013
  • 8
  • 0

Bifodan A/S

http://www.bifodan.com

Bifodan specialises in the development and production of probiotic products. The products are produced in either capsule, tablet or powder form and can either be sold as branded goods, or as own label products if business partners wish to market Bifodan products under their own brand. Furthermore, we also possess considerable experience in contract manufacturing. The company is in the process of obtaining exclusive patents within the lactic acid bacteria area and is constantly working towards being the preferred supplier and business partner of businesses worldwide.

  • 12/8/2013
  • 7
  • 0

WraSer Pharmaceuticals

http://www.wraser.com

WraSer Pharmaceuticals is an emerging pharmaceutical company that identifies, develops, and markets proprietary pharmaceutical products to physicians and pharmacies throughout the United States. WraSer's professional, results-oriented staff, combined with our strategic business alliances and innovative sales model have established WraSer as a pace setter in its market category. Founded in 2002, WraSer Pharmaceuticals is committed to bringing proprietary products to market each year and expanding it sales force annually. WraSer will continue to leverage its collective Upper and Lower Respiratory, Dermatology, and Pain Management expertise to keep developing a portfolio of innovative, therapeutically safe and effective products.

  • 12/8/2013
  • 10
  • 0

MacroMed , Inc.

http://www.macromed.com

Established in 1995, MacroMed is a specialty biopharmaceutical company focused on developing and commercializing innovative pharmaceutical products utilizing its proprietary polymer technologies. MacroMed collaborates with major pharmaceutical and biotechnology companies and has its own pipeline of several products in various stages of preclinical and clinical development for cancer management (OncoGel®, Cytoryn), moderate to moderately severe pain (Dolotyn) and growth hormone deficiency (Ascentra).

  • 12/8/2013
  • 7
  • 0

Quest PharmaTech Inc.

http://www.questpharmatech.com

Quest PharmaTech Inc. is engaged in the development and commercialization of new pharmaceutical products. The Company’s is developing a series of products for the treatment of cancer and dermatological conditions based on its photodynamic and sonodynamic therapy platform. Quest is developing these compounds as drugs, as well as developing means of activating and delivering them to target tissues. The Company’s lead product, SL017, is a topical formulation indicated for dermatology applications. A second product from the SonoLight platform, SL052, is an injectable formulation that is in late-stage pre-clinical development for prostate cancer treatment. Quest has entered into a license agreement with KMH Co., Ltd ("KMH") to market the Company's hair removal product, SL017, in Asia. (Source: ARS)

  • 12/8/2013
  • 7
  • 0

Western Research Laboratories

http://www.wrlonline.com

Western Research Laboratories was founded in 1934 by Dr. William McClymonds of Denver, Colorado. Dr. McClymonds built a strong foundation that quickly made Western Research Laboratories a great success. The philanthropic nature of Dr. McClymonds - his silent charitable donations and kind nature made him a cherished and respected member of the Denver community. His humane and ethical essence was the very foundation upon which Western Research Laboratories was developed. Dr. McClymonds was described as a 'genius' in chemistry by one of his obituary authors. He developed the natural thyroid medications, Westhroid and Nature-Throid, which remain two of the most popular natural forms of thyroid treatment to date. Natural thyroid hormone treatment instantly became Western Research Laboratories signature medication, and we continue to be leaders in this field. In 1949, under the title of National Glandular Society, Western Research Laboratories initiated the very first meeting of the American Society of Bariatric Physicians (ASBP).

  • 12/8/2013
  • 15
  • 0

Note

Not found any data